Search

Displaying results 7081 - 7090 of 10000 in total
  1. Pathway

    Cardiolipin Biosynthesis CL(8:0/a-21:0/25:0/a-25:0)

    smpdb.ca/view/SMP0369289
    Metabolic

    Last, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  2. Pathway

    Cardiolipin Biosynthesis CL(8:0/a-21:0/a-21:0/22:0)

    smpdb.ca/view/SMP0369290
    Metabolic

    Last, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  3. Pathway

    Cardiolipin Biosynthesis CL(a-13:0/a-21:0/23:0/23:0)

    smpdb.ca/view/SMP0369343
    Metabolic

    Last, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  4. Pathway

    Cardiolipin Biosynthesis CL(a-15:0/a-21:0/22:0/24:0)

    smpdb.ca/view/SMP0369673
    Metabolic

    Last, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  5. Pathway

    Cardiolipin Biosynthesis CL(a-15:0/a-21:0/25:0/25:0)

    smpdb.ca/view/SMP0369687
    Metabolic

    Last, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  6. Pathway

    Cardiolipin Biosynthesis CL(15:0/20:0/a-21:0/a-25:0)

    smpdb.ca/view/SMP0495568
    Metabolic

    Last, cardiolipin synthase catalyzes the synthesis of cardiolipin by transferring a phosphatidyl group from a second CDP-diacylglycerol to PG. It requires a divalent metal cation cofactor.

    Drugs: NADH · Cytidine-5'-Triphosphate · sn-glycerol 3-phosphate · Pyrophosphoric acid · Dihydroxyacetone phosphate
  7. Indication

    Gastroesophageal Reflux Disease With Esophagitis

    go.drugbank.com/conditions/DBCOND0125782
    Drugs: Simethicone
    Synonyms: Gastro-esophageal reflux disease with esophagitis, without bleeding
  8. Indication

    Symptomatic Epilepsy

    go.drugbank.com/conditions/DBCOND0119818
    Drugs: Gamma-amino-beta-hydroxybutyric acid
    Synonyms: Epilepsy, unspecified, not intractable, without status epilepticus
  9. Drug

    Salicylic acid

    go.drugbank.com/drugs/DB00936
    ApprovedInvestigationalVet approved

    A compound obtained from the bark of the white willow and wintergreen leaves, and also prepared synthetically. It has bacteriostatic, fungicidal, and keratolytic actions. … Its salts, the salicylates, are used as analgesics.

    Mixtures: Zaol Doctors Order Scalp Scaling, Zaol Doctors Order Synergy BoosterCategories: Cytochrome P-450 Substrates, Non COX-2 selective NSAIDS
  10. Drug

    Zapomeran

    go.drugbank.com/drugs/DB21761
    Approved

    Zapomeran, marketed under the brand name Kostaive (ARCT-154), is a self-amplifying mRNA COVID-19 vaccine for individuals 18 years and older. … Self-amplification allows for the use of lower doses while providing higher immunogenicity compared to a conventional mRNA COVID-19 vaccine.